Sequential Treatment With Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Lenalidomide (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 03 Jan 2017 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Status changed from recruiting to active, no longer recruiting.